Clinical management

Understanding on and off label prescribing

Understanding on- and off-label prescribing

What does on-label and off-label prescribing mean in myopia management? Here we explore this topic from the point of view of medications and medical devices, what regulatory approvals mean and how this applies to decision making and clinical processes such as informed consent.

minimise overcorrection avoid pseudomyopia

What is pseudomyopia? Avoiding overcorrection in children

How can we identify pseudomyopia? The IMI defines myopia as -0.50D or more when accommodation is relaxed. Yet recent data indicates that a quarter of 6-year-olds may present as myopic when they’re in fact exhibiting pseudomyopia. Explore more on this topic and how to relax accommodation for accurate refractions in children.

Putting Myopia Management Standard Of Care Into Action

In 2021, the World Council of Optometry (WCO) passed a resolution that publicly declares support for myopia management as standard of care. Since then, CooperVision has supported the WCO to empower eye care professionals to put this into action, with a multilingual online resource launched and more being added throughout 2022. Explore and learn more here.

Monocular Myopia Management

Monocular Myopia Management: unilateral and anisometropic myopia

How should you best manage children with unilateral or anisometropic myopia? Learn about what drives aniso-myopic development, associations with amblyopia and ocular pathology, and the evidence base for orthokeratology to slow aniso-myopic eye growth.

How much axial length growth is normal?

What amount of axial length growth be expected in myopes versus emmetropes, and how can you tell if your myopia control treatment is working? This important clinical reference provides all this information and more on axial growth in younger and older children, emmetropes and myopes, and even data on typical myopia stabilization.

Selecting an option: Clinical Decision Trees in myopia management

There is no one-size-fits-all when prescribing for childhood myopia control. Which option should you choose? In this important reference article, we ask you to consider three key questions which form clinical decision trees in myopia management.

managing treating high myopia

How should we manage high myopia?

Children, teens and adults with high myopia need special consideration of not just myopia control, but the best type of myopia correction and the importance of ocular health management. Do high myopes progress more quickly? What are the risks and management options?

Which clinical tests are required for myopia management?

Which clinical tests are required for myopia management? Here we take you through the recommendations of the International Myopia Institute (IMI) Clinical Management Guidelines Report, with references to several more of the IMI Reports including the latest Volume in 2021. You have everything you need to get started – learn more here.

how to use growth chart

How to Use Axial Length Growth Charts

Growth charts are commonly used in childhood health and are easily understood by parents. When applied to myopia management, axial length growth charts can allow individualized decisions on treatment strategy and efficacy. What charts are available now and how can you use them in practice? Here we explain how to use axial length growth charts from initial diagnosis to treatment strategy and long term monitoring.

Three clinical pillars for myopia management

Once the myopia management message has been communicated to the parent and patient – information on expectations, efficacy and safety – and the initial correction has been selected, there are three key areas of clinical focus.